SLC1A2

SLC1A2 Molekülinformation

Englischer Name	Excitatory amino acid transporter 2	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	2	Target-Alias	GLT1，Glutamate/aspartate transporter II，Sodium-dependent glutamate/aspartate transporter 2，Solute carrier family 1 member 2，SLC1A2，EAAT2
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	Excitatory amino acid transporter 2
Target-Alias	GLT1，Glutamate/aspartate transporter II，Sodium-dependent glutamate/aspartate transporter 2，Solute carrier family 1 member 2，SLC1A2，EAAT2
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	2
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

SLC1A2 Produktliste

Attribut
Protein (1)
Produktbibliothek
Online (1)
Spezies
Human (1)
Etikett
His Tag & Flag Tag (1)
Marker
Unconjugated (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
SL2-H52D6	Human	HEK293	Human SLC1A2 Protein, Flag,His Tag (Detergent)				In den Warenkorb legen

Gesamtmenge1

SLC1A2 Molekülhintergrund

This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Improper regulation of this gene is thought to be associated with several neurological disorders. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2017]

SLC1A2 Molekülalias

DEE41, EAAT2, EIEE41, GLT-1, GLT1, HBGT

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
[18F]RP-115	[18F]RP-115	Phase 2 Clinical	Rio pharmaceuticals Inc	Alzheimer Disease; Dementia; Frontotemporal Dementia	Details
iQ-007	iQ-007	Phase 1 Clinical	iQure Pharma Inc	Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Neuralgia	Details

Produktrezensionen

E***a2026-04-29
0Menschen mögen
Human SLC1A2 Protein, Flag,His Tag (Detergent)
We used this a POC and it worked in some assays where we got informative data. It is great to see detergent-stabilized proteins becoming more available commercially.